Silibinin inhibits constitutive and TNFalpha-induced activation of NF-kappaB and sensitizes human prostate carcinoma DU145 cells to TNFalpha-induced apoptosis (Q43919085)

From Wikidata

Jump to navigation Jump to search

scientific article published in March 2002

Language	Label	Description	Also known as
English	Silibinin inhibits constitutive and TNFalpha-induced activation of NF-kappaB and sensitizes human prostate carcinoma DU145 cells to TNFalpha-induced apoptosis	scientific article published in March 2002

Statements

scholarly article

1 reference

Europe PubMed Central

28 November 2017

Silibinin inhibits constitutive and TNFalpha-induced activation of NF-kappaB and sensitizes human prostate carcinoma DU145 cells to TNFalpha-induced apoptosis (English)

1 reference

Europe PubMed Central

28 November 2017

prostate carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

S Dhanalakshmi

1

1 reference

Europe PubMed Central

28 November 2017

R P Singh

2

1 reference

Europe PubMed Central

28 November 2017

C Agarwal

3

1 reference

Europe PubMed Central

28 November 2017

R Agarwal

4

1 reference

Europe PubMed Central

28 November 2017

language of work or name

0 references

publication date

1 March 2002

1 reference

Europe PubMed Central

28 November 2017

1 reference

Europe PubMed Central

28 November 2017

21

1 reference

Europe PubMed Central

28 November 2017

1759-1767

1 reference

Europe PubMed Central

28 November 2017

11

1 reference

Europe PubMed Central

28 November 2017

https://scigraph.springernature.com/pub.10.1038/sj.onc.1205240

0 references

Skin cancer chemopreventive effects of a flavonoid antioxidant silymarin are mediated via impairment of receptor tyrosine kinase signaling and perturbation in cell cycle progression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205240

21 January 2018

Pro-inflammatory signaling: last pieces in the NF-kappaB puzzle?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205240

21 January 2018

NF-kappa B: ten years after

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205240

21 January 2018

I kappa B: a specific inhibitor of the NF-kappa B transcription factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205240

21 January 2018

Function and activation of NF-kappa B in the immune system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205240

21 January 2018

Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205240

21 January 2018

The NF-kappa B and I kappa B proteins: new discoveries and insights

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205240

21 January 2018

An essential role for NF-kappaB in preventing TNF-alpha-induced cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205240

21 January 2018

Inhibition of human carcinoma cell growth and DNA synthesis by silibinin, an active constituent of milk thistle: comparison with silymarin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205240

21 January 2018

Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205240

21 January 2018

Genistein inhibits NF-kappa B activation in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205240

21 January 2018

A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205240

21 January 2018

Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205240

21 January 2018

Tumor necrosis factor alpha and interleukin-1beta regulate the murine manganese superoxide dismutase gene through a complex intronic enhancer involving C/EBP-beta and NF-kappaB.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205240

21 January 2018

NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205240

21 January 2018

NF-kappaB-inducing kinase activates IKK-alpha by phosphorylation of Ser-176

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205240

21 January 2018

Mechanism for the protective effects of silymarin against carbon tetrachloride-induced lipid peroxidation and hepatotoxicity in mice. Evidence that silymarin acts both as an inhibitor of metabolic activation and as a chain-breaking antioxidant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205240

21 January 2018

Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205240

21 January 2018

Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced NF-kappaB activation by tea polyphenols, (-)-epigallocatechin gallate and theaflavins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205240

21 January 2018

Constitutive activation of IkappaB kinase alpha and NF-kappaB in prostate cancer cells is inhibited by ibuprofen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205240

21 January 2018

TNF-induced signaling in apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205240

21 January 2018

A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205240

21 January 2018

Effect of antioxidants on androgen-induced AP-1 and NF-kappaB DNA-binding activity in prostate carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205240

21 January 2018

Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205240

21 January 2018

Inhibitory effect of silibinin on ligand binding to erbB1 and associated mitogenic signaling, growth, and DNA synthesis in advanced human prostate carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205240

21 January 2018

Relationships between proto-oncogene expression and apoptosis induced by anticancer drugs in human prostate tumor cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205240

21 January 2018

Oxidative stress, caloric restriction, and aging

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205240

21 January 2018

Chemoprevention of cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205240

21 January 2018

NF-kappaB activation: the I kappaB kinase revealed?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205240

21 January 2018

Suppression of TNF-alpha-induced apoptosis by NF-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205240

21 January 2018

Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFkappaB p65 protein expression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205240

21 January 2018

TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205240

21 January 2018

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205240

21 January 2018

An overview of chemoprevention: current status and future prospects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205240

21 January 2018

Silymarin: a review of its clinical properties in the management of hepatic disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205240

21 January 2018

N- and C-terminal sequences control degradation of MAD3/I kappa B alpha in response to inducers of NF-kappa B activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205240

21 January 2018

Bridging the gap: composition, regulation, and physiological function of the IkappaB kinase complex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205240

21 January 2018

Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: implications for prostate cancer intervention

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205240

21 January 2018

The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205240

21 January 2018

Constitutive activation of NF-kappaB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells. Autocrine role of tumor necrosis factor and reactive oxygen intermediates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205240

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of tumor necrosis factor-alpha and interferon-gamma on the growth of human prostate cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205240

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205240

7 January 2021

based on heuristic

inferred from DOI database lookup

Innovative treatment programs against cancer: II. Nuclear factor-kappaB (NF-kappaB) as a molecular target

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205240

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.ONC.1205240

1 reference

Europe PubMed Central

28 November 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

28 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43919085&oldid=2104389918"